Authors
Latest:
Hilda Haynes-Lewis and Rosaleen Bloom on Financial Toxicity and Workplace Stressors for Patients Undergoing RadiationHilda Haynes-Lewis, PhD, ANP-BC, AOCNP; and Rosaleen Bloom PhD, APRN, ACNS-BC, AOCNS, discuss the ways a cancer diagnosis can impair an individual’s ability to work normally.
Latest:
Study suggests Lymphoma Patients With Depression or Anxiety Experience Shorter Survival TimesPatients with depression had a 37% higher risk of dying from their disease than patients without a mental health diagnosis.
Latest:
Nurse Practitioners in Cancer Research: Recruitment, Protocols, and DocumentationDocumentation is especially important for nurse practitioners in cancer research and can lead to improved patient recruitment, says an expert.
Latest:
Karmanos nurse wins MDONS Outstanding Oncology Nurse of the Year AwardAgnes Pilecki, BSN, RN, a nurse on Barbara Ann Karmanos Cancer Institute’s bone marrow transplant unit, has been named the Metro Detroit Oncology Nursing Society’s (MDONS) Outstanding Oncology Nurse of the Year.
Latest:
Approach Health Disparities From All AnglesApril is National Minority Health Month, highlighting the need for health care and community sectors to come together and improve cancer outcomes for underserved populations.
Latest:
Reanne Booker on Factors to Consider When Discussing Palliative RadiationReanne Booker, MN, NP, highlights factors that make a patient a good candidate for palliative radiation.
Latest:
Care Management Tools Can Mitigate Clinician BurnoutAlthough technology alone can’t solve clinician burnout, it can provide the means for organizations to provide better care while increasing efficiency and alleviating stress.
Latest:
Paula Anastasia on PARP Inhibitor Ineligibility Factors for Women With Ovarian CancerPaula Anastasia, RN, MN, AOCN, highlights circumstances in which patients may not be eligible to receive benefit with a PARP inhibitor.
Latest:
Bridging Communication Gaps: Comprehensive Care for Upper GI Cancer TreatmentExperts discuss how to facilitate open communication among the patient, caregivers, and the multidisciplinary team to ensure comprehensive care and alignment on treatment goals.
Latest:
Real-World Data Support Enfortumab Vedotin for Urothelial Carcinoma TreatmentReal-world data demonstrate significant outcome improvements with enfortumab vedotin in patients with unresectable or metastatic urothelial carcinoma.
Latest:
Cheryl VerStrate on the Pitfalls of Direct-to-Consumer Genetic TestsCheryl VerStrate, DNP, AGPCNP-BC, OCN, discusses why nurses should be prepared to discuss direct-to-consumer genomic testing with their patients.
Latest:
Cema-Cel Yields CR, Found Tolerable in CD19 CAR T-Cell Therapy–Naive R/R LBCLCema-cel was associated with largely durable CRs in patients with CD19 CAR T-cell therapy-naïve relapsed/refractory LBCL.
Latest:
Aliènne Salleroli on Starting the DEI Conversation in Oncology NursingAliènne Salleroli, MS, BSN, RN, OCN, underscores the importance of open dialogue surrounding diversity, equity, and inclusion in oncology leadership.
Latest:
Oncology Rapid Access Clinics: APPs Improve Outcomes for Acutely Ill PatientsOncology rapid-access clinics should be essential to patient care standards across the oncology continuum.
Latest:
Michelle Mollica on Individualizing Care Plans for Cancer SurvivorsMichelle Mollica, PhD, MPH, RN, OCN, of the National Cancer Institute, discusses how childhood cancer survivors may face different challenges than adult or geriatric patients.
Latest:
Bring A Nuanced Approach to Venous Thromboembolism ManagementUnderstanding various clot characteristics and bleeding risk factors can help providers carefully manage acute venous thromboembolism.
Latest:
Nurse Practitioners in Cancer Research: Recruitment, Protocols, and DocumentationDocumentation is especially important for nurse practitioners in cancer research and can lead to improved patient recruitment, says an expert.
Latest:
Kara Morris and Christine Wylie on Oral Cryotherapy for Chemotherapy-Induced Mucositis in Breast CancerKara Morris, MSN, RN, OCN; and Christine Wylie, MSN, RN, OCN, discuss the benefits of oral cryotherapy for patients receiving dose-dense doxorubicin.
Latest:
Bridging Communication Gaps: Comprehensive Care for Upper GI Cancer TreatmentExperts discuss how to facilitate open communication among the patient, caregivers, and the multidisciplinary team to ensure comprehensive care and alignment on treatment goals.
Latest:
Elizabeth Aronson Walks Through the Data Supporting Elranatamab Approval in Multiple MyelomaElizabeth Aronson, MSN, FNP-BCN, OCN, shares what stood out to her about the phase 2 MagnetisMM-3 trial assessing elranatamab in multiple myeloma.
Latest:
Five Researchers Awarded Pilot Project FundingEvery year, Huntsman Cancer Institute receives funding from the American Cancer Society to support the promising research of junior faculty.
Latest:
Rx Road Map: Abemaciclib (Verzenio)Sarah Montini, BSN, RN, OCN, provides an in-depth look at abemaciclib for the treatment of patients with breast cancer in a downloadable reference sheet.
Latest:
Unlocking Bladder Cancer: A Guide to Effective Diagnosis and StagingExperts share insights on standard work-up and staging practices for a patient with newly diagnosed bladder cancer.
Latest:
Hilda Haynes-Lewis and Rosaleen Bloom on Financial Toxicity and Workplace Stressors for Patients Undergoing RadiationHilda Haynes-Lewis, PhD, ANP-BC, AOCNP; and Rosaleen Bloom PhD, APRN, ACNS-BC, AOCNS, discuss the ways a cancer diagnosis can impair an individual’s ability to work normally.
Latest:
Recognition of the Advanced Practice Preceptor Role in OncologyA tiered level preceptor recognition program offers a cost-effective organizational intervention designed to acknowledge and incentivize the contributions of advanced practice preceptors.
Latest:
Chemotherapy Linked to Persistent Physical Health Decline in Breast Cancer SurvivorsBreast cancer survivors treated with endocrine therapy alone reported better long-term physical health outcomes compared with those who received chemotherapy.
Latest:
Niraparib-Based Triplet Therapy Offers OS Advantage in BRCA1/2+ mCRPCThe median overall survival with niraparib, abiraterone acetate, and prednisone was 30.4 months vs 28.6 months with abiraterone acetate and prednisone alone.
Latest:
Melanie Darvish on Receiving an ONS Scholarship and What it Means to Be An Oncology NurseMelanie Darvish, BSN, RN, shares her experience attending the Oncology Nursing Society (ONS) Congress with an ONS Scholarship.
